Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

NCT01844115 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Placebo
DRUG: Vilazodone

Sponsor

Forest Laboratories